Dr Michelle Deaker

At Employment Hero, we’re an ambitious group of people on a mission to make employment easier and more valuable. We believe that when work works, it works for everyone. As the all-in-one employment solution for businesses with big ambitions and their teams, we support you at every stage of the employee lifecycle. From recruitment to HR, compliance and payroll, we’re here to unleash your team’s full potential. Since our inception in 2014, we’ve had some pretty impressive growth (we’re talking 100% YoY). We reached unicorn status in 2022 and now serve 350,000 businesses globally. With more than 2.5 million users using our platform- we have no plans to slow down. To find out more, visit employmenthero.com

Vaxxas is commercializing novel technology that dramatically enhances the performance of existing and next-generation vaccines. The company believes its innovative needle-free technology will help the world in rethinking whats possible with vaccines.

At Employment Hero, we’re an ambitious group of people on a mission to make employment easier and more valuable. We believe that when work works, it works for everyone. As the all-in-one employment solution for businesses with big ambitions and their teams, we support you at every stage of the employee lifecycle. From recruitment to HR, compliance and payroll, we’re here to unleash your team’s full potential. Since our inception in 2014, we’ve had some pretty impressive growth (we’re talking 100% YoY). We reached unicorn status in 2022 and now serve 350,000 businesses globally. With more than 2.5 million users using our platform- we have no plans to slow down. To find out more, visit employmenthero.com

Diversity in venture capital leads to better decision making and fund performance, facilitating the success of the whole sector as well as the startups these VC’s invest in. However, despite the rapid growth of venture-backed companies, there are too few women making investment decisions in VC and investment in women founded startups has lagged, with solely women-led startups attracting only 0.7 per cent of Australian VC investments¹. WinVC is a women-led initiative, aiming to bring together women VC investors to develop new opportunities, facilitate collaboration and help foster female talent in the industry.

Vaxxas is commercializing novel technology that dramatically enhances the performance of existing and next-generation vaccines. The company believes its innovative needle-free technology will help the world in rethinking whats possible with vaccines.

OneVentures is a later-stage Venture Capital Firm, focused on scaling Technology and Healthcare companies through growth equity and credit. Since 2010, OneVentures has launched 7 funds, managing over AU$900M. But we do more than invest. We take companies to that all-important next stage, by actively shaping their future. We apply our years of international experience, operational and executional expertise to accelerate the growth of our portfolio.